Cellular and extracellular proteomic profiling of paradoxical low-flow low-gradient aortic stenosis myocardium.

cellular and extracellular matrix proteomics myocardial biopsies normal ejection fraction high-gradient aortic stenosis paradoxical low-flow low-gradient aortic stenosis transcatheter aortic valve implantation (TAVI)

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2024
Historique:
received: 11 03 2024
accepted: 22 08 2024
medline: 2 10 2024
pubmed: 2 10 2024
entrez: 2 10 2024
Statut: epublish

Résumé

Patients with severe aortic stenosis (AS), low transvalvular flow (LF) and low gradient (LG) with normal ejection fraction (EF)-are referred to as paradoxical LF-LG AS (PLF-LG). PLF-LG patients develop more advanced heart failure symptoms and have a worse prognosis than patients with normal EF and high-gradient AS (NEF-HG). Despite its clinical relevance, the mechanisms underlying PLF-LG are still poorly understood. Left ventricular (LV) myocardial biopsies of PLF-LG ( 73 cellular proteins were differentially abundant between the 2 groups. Among these, a network of proteins related to muscle contraction and arrhythmogenic cardiomyopathy (e.g., cTnI, FKBP1A and CACNA2D1) was found in PLF-LG. Extracellularly, upregulated proteins in PLF-LG were related to ATP synthesis and oxidative phosphorylation (e.g., ATP5PF, COX5B and UQCRB). Interestingly, we observed a 1.3-fold increase in cyclophilin A (CyPA), proinflammatory cytokine, in the extracellular extracts of PLF-LG AS patients ( Our study pinpointed novel candidates and processes with potential relevance in the pathophysiology of PLF-LG. The role of CyPA in particular warrants further investigation.

Identifiants

pubmed: 39355352
doi: 10.3389/fcvm.2024.1398114
pmc: PMC11443424
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1398114

Informations de copyright

© 2024 Elkenani, Barallobre-Barreiro, Schnelle, Mohamed, Beuthner, Jacob, Paul, Yin, Theofilatos, Fischer, Puls, Zeisberg, Shah, Mayr, Hasenfuß and Toischer.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Manar Elkenani (M)

Clinic for Cardiology & Pneumology, University Medical Center Goettingen, Goettingen, Germany.
Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Department of Biochemistry and Molecular Medicine, Medical School OWL, Bielefeld University, Bielefeld, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Goettingen, Germany.

Javier Barallobre-Barreiro (J)

King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, United Kingdom.

Moritz Schnelle (M)

DZHK (German Centre for Cardiovascular Research), Partner Site, Goettingen, Germany.
Department of Clinical Chemistry, University Medical Center Goettingen, Goettingen, Germany.

Belal A Mohamed (BA)

Clinic for Cardiology & Pneumology, University Medical Center Goettingen, Goettingen, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Goettingen, Germany.

Bo E Beuthner (BE)

Clinic for Cardiology & Pneumology, University Medical Center Goettingen, Goettingen, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Goettingen, Germany.

Christoph Friedemann Jacob (CF)

Clinic for Cardiology & Pneumology, University Medical Center Goettingen, Goettingen, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Goettingen, Germany.

Niels B Paul (NB)

Department of Medical Bioinformatics, University Medical Center Goettingen, Goettingen, Germany.

Xiaoke Yin (X)

King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, United Kingdom.

Konstantinos Theofilatos (K)

King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, United Kingdom.

Andreas Fischer (A)

DZHK (German Centre for Cardiovascular Research), Partner Site, Goettingen, Germany.
Department of Clinical Chemistry, University Medical Center Goettingen, Goettingen, Germany.

Miriam Puls (M)

Clinic for Cardiology & Pneumology, University Medical Center Goettingen, Goettingen, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Goettingen, Germany.

Elisabeth M Zeisberg (EM)

Clinic for Cardiology & Pneumology, University Medical Center Goettingen, Goettingen, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Goettingen, Germany.

Ajay M Shah (AM)

King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, United Kingdom.

Manuel Mayr (M)

King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, London, United Kingdom.

Gerd Hasenfuß (G)

Clinic for Cardiology & Pneumology, University Medical Center Goettingen, Goettingen, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Goettingen, Germany.

Karl Toischer (K)

Clinic for Cardiology & Pneumology, University Medical Center Goettingen, Goettingen, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site, Goettingen, Germany.

Classifications MeSH